Clinical trial · Interventional
Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH
Fatigue in Breast Cancer Patients Undergoing Radiotherapy-Electronic Self-Management Resource Training for Mental Health (eSMART-MH)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if an avatar-based depression self-management intervention (eSMART-MH) once a week for the duration of the participant's radiation treatment will significantly reduce depressive symptoms. Investigators also seek to explore how women with breast cancer describe their mood using prompted and unprompted speech through electronic social media and interviews. Participants will be randomized into the eSMART-MH group or the theater testing (attention control) group. In addition to the assigned interventions, participants will be asked to complete questionnaires and interviews with the study staff.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| eSMART-MH | Behavioral | — | UNRESOLVED |
| Mobile Mood Tracking (Mood 24/7) | Other | — | UNRESOLVED |
| Theater Testing Workshop | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- eSMART-MH
- description
- Participants undergoing radiation treatment for breast cancer will receive the Electronic Self-Management Resource Training for Mental Health (eSMART-MH) intervention.
- interventionNames
- Behavioral: eSMART-MH
- Other: Mobile Mood Tracking (Mood 24/7)
- type
- OTHER
- label
- Theater Testing
- description
- Participants undergoing radiation treatment for breast cancer will participate in a theater testing workshop.
- interventionNames
- Behavioral: Theater Testing Workshop
Primary outcomes (1)
- measure
- Change in an Inventory of Depressive Symptomatology-Self Reported (IDS-SR) score
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients seen in the Emory Breast Center at The Emory Clinic and Emory Midtown Hospital who are treated with curative intent. * Score of 8 or higher on the Inventory of Depressive Symptomology - Self Reported (IDS-SR) test
References
Publications (0)
Data not yet available